Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Cyteir Therapeutics Inc.

    NASDAQ: CYT · Real-Time Price · USD
    3.02
    -0.07 (-2.27%)
    At close: Mar 15, 2024, 9:00 PM

    Cyteir Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2022 FY 2021
    Period Ending Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a
    Cost of Revenue
    		 1.38M 479K
    Gross Profit
    		 -1.38M -479K
    Operating Income
    		 -48.17M -42.26M
    Interest Income
    		 n/a 133K
    Pretax Income
    		 -46.06M -42.13M
    Net Income
    		 -43.95M -41.65M
    Selling & General & Admin
    		 13.55M 11.3M
    Research & Development
    		 34.62M 30.96M
    Other Expenses
    		 2.11M 133K
    Operating Expenses
    		 48.17M 42.26M
    Interest Expense
    		 n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a
    Cost & Expenses
    		 48.17M 42.26M
    Income Tax Expense
    		 -2.11M -479K
    Shares Outstanding (Basic)
    		 35.27M 35.19M
    Shares Outstanding (Diluted)
    		 35.27M 35.19M
    EPS (Basic)
    		 -1.25 -1.18
    EPS (Diluted)
    		 -1.25 -1.18
    EBITDA
    		 -47.5M -41.78M
    EBIT
    		 -46.73M -42.26M
    Depreciation & Amortization
    		 668K 479K

    Add to Watchlist